Citigroup Lowers Estimates for Life Tech, Raises Them for Illumina | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Citigroup yesterday revised its estimates for Life Technologies and Illumina, lowering fourth-quarter 2011 earnings per share estimates for Life Tech while raising EPS for Illumina.

Analyst Amit Bhalla lowered his EPS estimate for Life Tech for the fourth quarter to $1.03 from $1.06, while also reducing his revenue estimate for full-year 2011 to $3.72 billion from an earlier estimate of $3.74 billion. EPS for the full year was lowered to $3.70 from $3.73.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.